More than 10 percent of patients treated
with aspirin therapy for primary cardiovascular disease prevention were likely inappropriately prescribed medication, according to a new study in the Journal of the American College of Cardiology that examined practice variations in aspirin therapy.
Cumulative incidence of liver cancer in the group treated
with aspirin therapy was significantly lower than that in the untreated group in five years.
Not exact matches
After excluding patients
with liver cancer before the follow ‐ up index dates, 1,553 patients who had continuously received daily
aspirin for at least 90 days were randomly matched 1:4
with 6,212 patients who had never received anti platelet
therapy by means of propensity scores consisting of baseline characteristics, the index date and nucleos (t) ide analogue (NA) use during follow ‐ up.
Josep Rodes - Cabau, M.D., of Laval University, Quebec City, Canada, and colleagues randomly assigned 171 patients
with an indication for atrial septal defect (ASD) closure and no history of migraine to receive dual antiplatelet
therapy (
aspirin + clopidogrel [the clopidogrel group], n = 84) or single antiplatelet
therapy (
aspirin + placebo [the placebo group], n = 87) for 3 months following transcatheter ASD closure.
Adding the antiplatelet drug ticagrelor to
aspirin as long - term
therapy after a heart attack significantly reduced the rate of subsequent death from cardiovascular causes, heart attack or stroke,
with the benefit appearing to accrue for nearly three years, according to a study presented at the American College of Cardiology's 64th Annual Scientific Session.
Small peptides have the benefits of small molecule drugs, like
aspirin, and large antibody
therapies, like rituximab,
with fewer drawbacks.
For patients
with sore throat, physicians should recommend analgesic
therapy such as
aspirin, acetaminophen, nonsteroidal anti-inflammatory drugs, and throat lozenges, which can help reduce pain.
They estimated that participants
with elevated CAC scores (> 100) were 2 − 4 times more likely to benefit from
aspirin therapy than to be harmed, even if they did not qualify for
aspirin use according to current AHA guidelines.
From our roots under the scientific leadership of renowned neurologist Dr. Henry Barnett - whose work
with Aspirin as a preventive
therapy for heart attack and stroke remains one of the most important developments in 20th century medicine - the Institute has applied that formula to become a national leader in biological, clinical and imaging research.
Additional treatment
with aspirin resulted in significantly higher incidences of any major bleeding, gastrointestinal tract bleeding, and other major bleeding compared
with no additional antiplatelet
therapy.
Dr. Kirkman stresses that people
with diabetes who are taking
aspirin — and have no history of heart attack — should talk to their doctor and see if he or she recommends continuing the
therapy.
Yet few among us today have not benefited from such trials, whether the lessons were positive (e.g., the benefits of an
aspirin a day to reduce heart - attack risk) or negative (e.g., the increased risk of cancer associated
with long - term hormone - replacement
therapy).
Dogs taking oral tetracycline or on
aspirin therapy should not take Pepto - Bismol because it has been shown to interfere
with the absorption of these two medications.
It includes body weight restriction, exercise control and analgesic
therapy with nonsteroidal anti-inflammatory drugs (NSAIDs) such as
aspirin, phenylbutazone, carprofen and etodolac.
Individuals below 19 years of age
with a rare and fatal disease of Reye's syndrome, and receiving «long - term»
aspirin therapy
Does adjuvant
aspirin benefit patients
with schizophrenia spectrum disorders who are on antipsychotic
therapy?